Roots Analysis, Research, Pharma, Biotech, Analysis, Market Research, Industry Reports, Business Report, Global

>

Roots Analysis, Research, Pharma, Biotech, Analysis, Market Research, Industry Reports, Business Report, Global

Roots Analysis has done a detailed study on “HPAPI and Cytotoxic Drugs Manufacturing (3rd Edition) 2020-2030”, covering key aspects of the industry’s evolution and identifying potential future growth opportunities.

 

To order this 300+ page report, which features 75+ figures and 150+ tables, please visit this https://www.rootsanalysis.com/reports/view_document/hpapi-and-cytotoxic-drugs-manufacturing/299.html

 

Key Market Insights

  • Close to 120 companies across the globe claim to possess the required expertise and infrastructure to offer contract manufacturing services for HPAPIs and cytotoxic drugs
  • The market is fragmented, featuring the presence of both established players and new entrants based in different geographies that claim to be capable of manufacturing highly potent products, at varying scales of operation
  • In order to acquire competencies across the supply chain and cater to evolving needs of sponsors, companies offering services across different scales of operation have established presence in various geographical regions
  • In recent years, a steady increase in partnership activity has been observed in this domain; a variety of deals have been inked related to highly potent drug products
  • In order to enhance the core competencies in this domain, CMOs are actively investing in upgrading existing infrastructure and expanding their respective manufacturing capacities
  • Most of the installed, global HPAPI and cytotoxic drug manufacturing capacity belongs to established CMOs, accounting for close to 75% of the available capacity across various geographies
  • Case-in-point: ADCs represent a significant growth opportunity; over 30 CMOs currently extend their services to manufacture one or multiple components of an ADC molecule
  • We expect highly potent drug developers to continue to outsource their manufacturing operations in the mid to long term, causing service-based revenues to grow at an annualized rate of more than 10%
  • In the long-term, the projected opportunity for the contract manufacturing of HPAPIs and cytotoxic drugs is likely to be well distributed across various dosage forms, nature of molecules and sizes of contract service providers

For more information, please visit https://www.rootsanalysis.com/reports/view_document/hpapi-and-cytotoxic-drugs-manufacturing/299.html  

 

Table of Contents

 

  1. PREFACE
    1.1. Scope of the Report
    1.2.       Research Methodology
    1.3.       Chapter Outlines

    2.         EXECUTIVE SUMMARY

    3.         INTRODUCTION
    3.1.       Chapter Overview
    3.2.       Overview of Highly Potent Active Pharmaceutical Ingredients (HPAPIs)
    3.2.1.    Classification based on Potency of Pharmacological Ingredients
    3.2.2.    Types of HPAPIs
    3.2.3.    Challenges Associated with Handling HPAPIs
    3.2.4.    Considerations for Handling HPAPIs
    3.2.5.    Contract Manufacturing of HPAPIs and Cytotoxic Drugs
    3.2.5.1. Selection of a Suitable CMO Partner for HPAPI Manufacturing
    3.2.6.    Regulatory Considerations for HPAPI Manufacturing
    3.2.7.    Concluding Remarks
  2. MARKET LANDSCAPE
    4.1. Chapter Overview
    4.2.       HPAPI and Cytotoxic Drugs Contract Manufacturers: Overall Market Landscape
    4.2.1.    Analysis by Year of Establishment
    4.2.2.    Analysis by Company Size
    4.2.3.    Analysis by Scale of Operation
    4.2.4.    Analysis by Type of Service(s) Offered
    4.2.5.    Analysis by Type of Product
    4.2.6.    Analysis by Type of Pharmacological Molecule
    4.2.7.    Analysis by Location of Headquarters
    4.2.8.    Analysis by Location of Manufacturing Facilities
    4.2.9.    Analysis by Facility Size
    4.2.10. Analysis by Type of Highly Potent Finished Dosage Forms (FDFs)
    4.2.11. Analysis by Type of Primary Packaging

Contact:
Gaurav Chaudhary
gaurav.chaudhary@rootsanalysis.com

Roots Analysis
A430, 4th Floor,
Bestech Business Towers, Sector 66, Mohali, India
sales@rootsanalysis.com
+1 (415) 800 3415
+44 (122) 391 1091
Web: https://www.rootsanalysis.com/
LinkedIn: https://in.linkedin.com/company/roots-analysis
Twitter: https://twitter.com/RootsAnalysis

Share:

Keywords: roots analysis,research,pharma,biotech,analysis,market research,industry reports,business report,global

Comments

Other related blogs

The customers who need to purchase the compartments

By : JK Rowling CBD Gummies

  JK Rowling CBD Gummies The customers who need to purchase the compartments of JK Rowling CBD..


The customers who need to purchase the compartments

By : JK Rowling CBD Gummies

  JK Rowling CBD Gummies The customers who need to purchase the compartments of JK Rowling CBD..


How To Buy An MTP Abortion Pill Kit Online?

By : Privacypillrx

Medication abortion is the process of terminating a pregnancy in the early stage with help of aborti..


The RNAi therapeutics market is anticipated to grow at an annualized rate of more than 45%, till 2030, claims Roots Analysis

By : Roots Analysis

The recent approval of first RNAi therapeutic, ONPATTROTM, has caused a surge in interest of the ind..